Cargando…
A Caulobacter crescentus Microbicide Protects from Vaginal Infection with HIV-1(JR-CSF) in Humanized Bone Marrow-Liver-Thymus Mice
Over 2 million people are infected with HIV-1 annually. Approximately half of these new infections occur in women residing in low-income countries, where their access to and control over HIV-1 preventative measures are often limited, indicating that female-controlled prevention options for HIV-1 are...
Autores principales: | Farr Zuend, Christina, Nomellini, John F., Smit, John, Horwitz, Marc S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714793/ https://www.ncbi.nlm.nih.gov/pubmed/31243127 http://dx.doi.org/10.1128/JVI.00614-19 |
Ejemplares similares
-
Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors
por: Farr, Christina, et al.
Publicado: (2013) -
Development of an HIV-1 Specific Microbicide Using Caulobacter crescentus S-Layer Mediated Display of CD4 and MIP1α
por: Nomellini, John F., et al.
Publicado: (2010) -
Long-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice
por: Melody, Kevin, et al.
Publicado: (2020) -
Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity
por: Donius, Luke R., et al.
Publicado: (2016) -
Generation of a Dual-Target, Safe, Inexpensive Microbicide that Protects Against HIV-1 and HSV-2 Disease
por: Farr Zuend, Christina, et al.
Publicado: (2018)